All Episodes
Oncology Times - OncTimes Talk — 198 episodes
The Smartest Oncologist in the World? – Well, at least in the US!
Cancer-Related Fatigue
Bilateral Prophylactic Mastectomy for DCIS
10th European Congress on Perspectives in Lung Cancer, Brussels
More from the ASH Annual Meeting!
Program 4, Day 4, Monday Dec 8
Program 3, Monday Dec 7
Program 2, Sunday Dec. 6
Program 1, First Day, Dec. 5
ASH Annual Meeting
NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress
KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination
CML: Hagop Kantarjian on Treating Patients with the T315I Mutation
Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies
Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision
Integrating Palliative & Standard Care
The Importance of “Competitive Mortality” in Oncology Care
Final Rule for Medicare ACOs
Will CMS Cast Its Eye Toward Oncology?
Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World'
From the European Hematology Association 2010 Congress: For Patients with Follicular Lymphoma, Rituximab Maintenance Therapy Cuts Risk of Recurrence in Half (Phase III PRIMA Study)
OT Clinical Advisory Editor for Hematology/Oncology Mikkael Sekeres, MD, MS
OT Clinical Advisory Editor for Oncology Ramaswamy Govindan, MD
Treatment Recommendations for High- & Low-Risk Early Breast Cancer: New Data from EBCC 7, the European Breast Cancer Conference
Pregnancy & Breast Cancer: New Updates from EBCC 7, the European Breast Cancer Conference
Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
Research Policy Expert: Overhaul Cancer Research Priorities Globally Now!
Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality
The Disappointment of the NSABP C-08 Trial
Advanced Biliary Cancer Controlled with Cetuximab Added to GEMOX
Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos
Stage IV Pancreatic Islet Cell Tumors: Sunitinib Doubles Progression-Free Survival in Phase III Study
Talking About Leadership With Brian J. Bolwell, MD, FACP
A Closer Look at Ultra-Rare Cancers
What I Love About Hematology/Oncology: Muzaffar H. Qazilbash, MD
What I Love About Hematology/Oncology: Margaret Kasner, MD, MSCE
What I Love About Hematology/Oncology: Pamela Crilley, DO
How Health IT is Changing Oncology
Are You Providing Adequate Palliative Care?
CMS Innovation
Chemotherapy Order Sets—Lessons Learned
Are You Giving Patients What They Want?
A Clinical Research Consortium for MDS
The Role of Patient Education in Survivorship Care
How CancerLinQ Will Change Patient Care
How Drug Shortages Affect Oncology
The Thinking Behind ASCO’s Top Five List
The Value of In-Person Meetings
Oncology Practices Expect Big Change
Cancer’s Existential Impact on Survivors
How Should Physicians Be Paid?
ASCO 2022 Small Bytes Episode 2: Dr. Julia C. Tchou on Telehealth Weight Loss Program for Breast Cancer Survivors
ASCO 2022 Small Bytes: Dr. Alexander I. Spira on KRYSTAL-1 for Patients with Advanced/Metastatic NSCLC
Colleague Conversations: A Look at Germline Predisposition to Hematologic Malignancies
Refugees & Cancer Care: Ukraine, Lebanon & Beyond Featuring Dr. Richard Sullivan & Dr. Deborah Mukherji
Unpacking the Role of Emotions in Mastectomy Decisions with Clara N. Lee, MD
Mitigating the Effects of Climate Change on Cancer Care With Robert A. Hiatt, MD, PhD
Roswell Park’s Candace S. Johnson & Congressman Brian Higgins on the Promise of Biden’s Cancer Moonshot
ASH 2021 Revisited: Plenary Sessions, ZUMA-7 & COVID Vaccines
OncTimes Talk Research Review February 2022: Dr. Stephen Hahn, COVID, 2021 World Cancer Leaders’ Summit & Cervical Cancer News
ASH 2021 Recap: COVID-19 in Patients with Acute Leukemias & Myelodysplasia In Conversation with Dr. Pinkal Desai
ASH 2021 Recap: Multi Omics Sheds New Light on Malignant Transformation from Myeloproliferative Neoplasm to AML
Study Recap: After 6 Months, Pfizer COVID Vaccine Remains Effective Against Hospitalizations
Colleague Conversations: Palliative Care in Oncology
Research Spotlight: MET Amplification as Driver for NSCLC
OncTimes Talk Research Review May 2021
Straight Talk with Dr. Brian J. Bolwell: Values
Straight Talk with Dr. Brian J. Bolwell: Moments
Young Investigators: Liam Holt, PhD, Examines High Compression on Cells & Cancer
Straight Talk with Dr. Brian Bolwell: Letting it Go
Full Compliance With Adjuvant Endocrine Therapy Brings 15 Percent Superior Survival in Patients With Breast Cancer
Being Obese & Overweight Reduces Efficacy of Extended Endocrine Therapy in HR+ Breast Cancer
ASCO 2023: Neoadjuvant Pembrolizumab Brought Big Benefit in Early-Stage Non-Small Cell Lung Cancer with Heather A. Wakelee, MD, FASCO
ASCO 2023: How AI Can Help Physicians Communicate with Dying Patients Better & Also Reduce Costs
Targeted Adjuvant Therapy in Non-Small Cell Lung Cancer with Roy Herbst, MD PhD
Targeted Adjuvant Therapy in Non-Small Cell Lung Cancer with Roy Herbst, MD PhD
Emerging Cancer Treatments for Esophageal Cancer with Brian Henick, MD
Meet the New Oncology Times Editorial Board Chair: Stephanie L. Graff, MD, FACP
Ravi B. Parikh, MD, on How Machine Learning-Triggered Reminders Can Improve End-of-Life Care for Cancer Patients
Deanna Gerber, MD, on Navigating Cervical Cancer Screening
January Research Review: Promising Results in HemOnc Clinical Trials
Unraveling a Complex Disease: Gary K. Schwartz, MD, on Sarcoma Research Highlights, Targeted Agents & Future Directions
ASH 2022: David Sallman, MD, Discusses Positive Phase I Dose Escalation Data for PRGN-3006 UltraCAR-T in AML Patients
Anil K. Rustgi, MD, on the Current State of Colorectal Cancer Screening
Small Bytes: How ctDNA Liquid Biopsies Can Detect Myeloid Malignancies & Occult Tumors
Small Bytes: Phase I Study Finds Pan-AKT Inhibitor Ipatasertib Safe & Effective, Featuring Carolyn McCourt, MD
Dr. Lisa Newman on Eliminating Racial Disparities in Breast Cancer
HemOnc Highlights: Dr. Naveen Pemmaraju on the Benefits of Tagraxofusp for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
5 Questions on Making Cardio-Oncology More Accessible to Diverse Patient Populations with Dr. Sandeep Mittan
ESMO 2022: For Desmoid Tumor, First Proven Therapy Shows Clear Benefit, “Should Become Standard”
ESMO 2022: PATHFINDER Presents Screening Paradigm Shift with A Blood Test to Facilitate Early Detection
OncTimes Talk Research Review August 2022: Focus on Breast Cancer
Metastatic Hormone-Sensitive Prostate Cancer: Extending Life By Adding a Third Drug to Standard Regimens with Dr. Vincent Khoo
Liquid Biopsy ctDNA Prediction of Lung Cancer Relapse “Ready for Prime Time”
ASCO 2022 Small Bytes Episode 3: Dr. Marla Lipsyc-Sharf on Personalized ctDNA Testing in Late, HR+, HER2-Negative Breast Cancer
Adjuvant Atezolizumab: No Survival Benefit in Triple-Negative Breast Cancer
Gene Test Shows Which Triple-Negative Breast Cancers Do Not Need Pre-Op Pembrolizumab
Triple Therapy for Patients With Mutated FLT3 Gene in Acute Myeloid Leukemia
Important Mantle Cell Lymphoma Findings From the Sympatico Study
World’s Largest Prostate Cancer Trial, STAMPEDE, Celebrates 20 Years of Progress
Doublet Inhibitor Therapy Restrains Metastatic EGFR-Mutated NSCLC Progression
Gene-Targeted Agent Brings Clinical Benefit in R/R Acute Leukemias
INTERLACE Study Boosts Cervical Cancer Survival
Afatinib Recommended for Non-Small Cell Lung Cancer With Uncommon EGFR Mutations
RET Fusion-Targeted Drug Doubles Progression-Free Survival in NSCLC Patients
Adjuvant Radiotherapy No Benefit After Radical Prostatectomy
Collagen-Bound Interleukin 12 Converts “Cold” Tumors Into “Hot” Ones
Allogeneic Transplant for AML: Only in Patients Negative for Molecular Minimum Residual Disease
Antibody-Drug Conjugate Brings Success in High-Risk R/R Follicular Lymphoma
Pirtobrutinib After Covalent BTK Inhibitor - Double Refractory CLL
Relapsed or Refractory CLL - With Sameer A. Parikh, MBBS, and Alessandra Ferrajoli, MD
CLL Frontline Treatment - With Sameer A. Parikh, MBBS, & Alessandra Ferrajoli, MD
Sabestomig in Non-Small Cell Lung Cancer: Bi-Specific Antibody Safe and Active
Radicals Study Finds Adjuvant Radiotherapy No Benefit After Radical Prostatectomy
Double TKI Therapy Improves Responses in MET Amplification-Driven EGFR-Mutant Non-Small Cell Lung Cancer
Two Drug Combination Benefits Patients with nRAS-Mutated Melanoma Refractory to Checkpoint Inhibition
CLIC Protein Inhibition Key to Metformin’s Anti-Neoplastic Properties
Adjuvant ATR Inhibition Prolonged Life in Patients with Relapsed Small Cell Lung Cancer
Mitophagy Discovered as Potential Reason for AML’s Resistance to Venetoclax
Unintentional Bias of Breast Cancer Randomized Clinical Trial Interpretations Through Discontinuation Imbalance
Trastuzumab Deruxtecan Benefits Patients with HER2-Low Metastatic Breast Cancer Irrespective of ER Expression
Artificial Intelligence Model Predicts Overall Survival in Patients with Metastatic Breast Cancer
Axillary Dissection in Older Women With Clinically Node-Negative Breast Cancer
Variability of Biological Parameters Between Tumor Biopsy & Surgical Samples in Breast Cancer Patients
Collagen-Bound Interleukin 12 Converts “Cold” Tumors into “Hot” Ones
Lymphadenectomy Can Be Safely Omitted for Patients With Advanced Epithelial Ovarian Cancer Lacking Suspicious Lymph Nodes
MUC-1 Vaccine Delays Breast Cancer Distant Recurrence & Extends Survival
Neoadjuvant Checkpoint Inhibitor Combination Beats Standard Surgery With Adjuvant Immunotherapy in Macroscopic, Resectable Stage III Melanoma
Telehealth Triumphs for Palliative Care Delivery in Patients With Lung Cancer
Asciminib May Be a Safer, More Effective Treatment for Patients With Newly Diagnosed Chronic Myeloid Leukemia
Chemotherapy Before and After Surgery Improved Outcomes for Patients With Resectable Locally Advanced Esophageal Adenocarcinoma
Trastuzumab Deruxtecan Delays Progression in HR+, HER2-low, and HER2 Ultralow Breast Cancer After Endocrine Therapy
German Study Finds New Regimen for Hodgkin Lymphoma More Effective, Less Toxic
Study Finds Durvalumab Improved Progression-Free and Overall Survival in Limited Stage Small Cell Lung Cancer
Study Supports Osimertinib as Standard of Care for Patients With Locally Advanced EGFR-Mutated NSCLC
Earliest Detection of Cancer by Artificial Intelligence Analysis of Circulating Cell-Free DNA Fragmentomes
Kinase Inhibitor Delivers Synthetic Lethality to Enhance Radiotherapy in Glioblastoma
mRNA Vaccine + Checkpoint Inhibitor Combo Had Low Toxicity With Evidence of Efficacy in Advanced NSCLC
Bispecific Dual Checkpoint Blockade Extends Life & Slows Progression in Gastric & GE Junction Cancers
Exercise Deters Prostate Cancer Death & Progression
Bispecific T-cell Engager Antibody Brings Deep, Durable Remissions in R/R Multiple Myeloma
Exosome-Based Liquid Biopsy Promises Very Early Pancreatic Cancer Detection
Polyepitopic Personalized Vaccine Brought Durable Immune Responses & Clinical Benefit in Resected Head & Neck Cancers
Mesh-Supported Prepectoral Method of Breast Reconstruction After Breast Cancer Surgery
Radiotherapy Boost Protects Young Patients With Early Breast Cancer, High Dose Boost Not Needed
Breast-Conserving Therapy Effective for Ductal Carcinoma in Situ, But Questions Remain
Three-Node Breast Cancer Spread: Most Patients Can Safely Avoid Axillary Dissection
Artificial Intelligence Tool Predicts Postoperative Radiotherapy Lymphedema
Neoadjuvant Pembrolizumab Improves High-Risk Early Breast Cancer Outcomes
Preoperative Partial Breast Irradiation: Marked Benefit in Low-Risk Breast Cancer
Antibody-Drug Conjugate “Promising Efficacy” in HER2-Positive and HER2-Low Breast Cancer
Radiation Delivery by Mini Protein Brings Promise for Metastatic Urothelial & Other Solid Tumors
Advanced Melanoma: CheckMate 067 10-Year Data Show Prognoses Transformed By Checkpoint Inhibitors
Perioperative Checkpoint Inhibition Better for Muscle-Invasive Bladder Cancer
Preoperative Chemoradiation Ruled Out for Gastric or GE Junction Resectable Adenocarcinoma
Recurrent Glioma: Encouraging Responses to Autologous Myeloid Dendritic Cell Therapy
Resectable Stage III Melanoma: Unprecedented Survival Benefit With Pure Checkpoint Inhibitor Neoadjuvant Therapy
Therapeutic mRNA Vaccine Brings New Hope in Glioblastoma
Circulating Tumor DNA Directs Precision Management for Ovarian Cancer
Cardio-Oncology: Many Cancer Treatment Cardiotoxicities Still to Be Understood
ESMO Reports Neoadjuvant Therapy for TNBC, Combination Checkpoint Inhibition, Artificial Intelligence & More
Emerging Potential for Cell Therapies in Ovarian Cancer and Other Solid Tumors
Global Cooperation on Antibody-Drug Conjugates: Key Driver of Progress in HER2-Dependent Metastatic Breast Cancer Treatment
Breastfeeding is Safe After Treatment for BRCA-Positive Breast Cancer
World-Wide Clinical Perspectives from Chinese Society of Clinical Oncology’s Globally Upscale 2024 Annual Meeting
Breastfeeding After Hormone Receptor-Positive Breast Cancer: No Detectable Risk for Patients
Findings at ESMO 2024 Highlighting the Benefit of Neoadjuvant Therapies
A Multi-Drug Algorithm Used to Accurately Predict Best First-Line Treatments in Patients With Newly Diagnosed Acute Myeloid Leukemia
Immune-Related Adverse Events Predict Response to Checkpoint Inhibitor Monotherapy in Advanced Head & Neck Cancers
Proton Pump Inhibitors Bigger Impact on Dasatinib Efficacy in CML Than Previously Thought
Breastfeeding is Safe After Treatment for BRCA-Positive Breast Cancer
Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma
Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development
Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front
Digital Twin Brings AI Power to Individualize Cancer Management
Wnt Signaling Pathway Inhibitor Suggests Toxicity-Free Cure Potential for Hepatoblastoma
Anti-HER2 Combination Found Effective in HER2-Altered Bile Duct Cancers
FGFR-3 Inhibitor Has Early Clinical Activity in Advanced Urothelial Cancer
Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer
Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities
Novel Score Selects Patients With Intermediate Risk Prostate Cancer Safe for Active Surveillance
Striking Microbiome Bacterial Population Differences Distinguish Metastatic Prostate Cancer From Non-Metastatic Disease
Episode 1, A Precision Medicine Approach for Advanced Ovarian Cancer
Episode 2, HRD Testing Deep-Dive
Episode 3, Better Informed Patient Journeys
KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
From Ironman to Advocate: Tom Hulsey’s Journey Through Prostate Cancer and Purpose
Accurate and Actionable: How Oncologists Get Fast, Comprehensive Therapeutic Insights from the OncoExTra® Test
Empowering Cancer Care Through Movement: A Conversation with Sami Mansfield
Defying the Odds: Katie Coleman's Journey from Diagnosis to Advocacy
Making Comprehensive Genomic Profiling More Accurate for Everyone: The Importance of Patient-Matched Tumor-Normal Sequencing
Transforming colorectal cancer management with tumor informed ctDNA testing
Lessons in Resilience: Dr. Susan MacDonald's Healthcare Journey
Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities at High Risk